HopeStage
Back to all studies
CompletedNCT04141501

Psilocybin for Alcohol Use: Effects and Mechanisms

About this titleRead the official source — NCT04141501
Medication studyAges 18–60SwitzerlandAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 60 years.

Listed locations
ZurichSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: June 8, 2020
Recruitment status
Completed
Enrollment listed in the registry
37
Sponsor
University of Zurich
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Switzerland
Age range
From 18 Years to 60 Years
Official registry ID
NCT04141501
Official title
Show the full official title

Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy and Mechanism in Alcohol Use Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Zurich

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Zurich, a university.

Did this study involve medication?

Yes. The study involved medication, including Psilocybin and Placebo oral capsule.

Who was this study for?

Listed age limits: 18 years to 60 years.

Want to explore more studies?

Explore studies